Share buybacks · 2017–2025
Halozyme Therapeutics share buybacks
$342M+36.9% · FY2025
Halozyme Therapeutics (HALO) reported $342M in share buybacks for fiscal 2025, +36.9% year on year.
| Fiscal year | Share buybacks | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $342M | +36.9% | Open → |
| FY20242024-12-31 | $250M | −37.9% | Open → |
| FY20232023-12-31 | $402M | +101.2% | Open → |
| FY20222022-12-31 | $200M | −42.9% | Open → |
| FY20212021-12-31 | $350M | +133.2% | Open → |
| FY20202020-12-31 | $150M | −24.9% | Open → |
| FY20192019-12-31 | $200M | +$200M | Open → |
| FY20182018-12-31 | $0 | $0 | Open → |
| FY20172017-12-31 | $0 | — | Open → |
Share buybacks — Share buybacks are the cash a company spent during the year repurchasing its own stock, taken from the financing section of the cash-flow statement. Most companies buy back nothing at all — the line is absent rather than zero — so this ranking covers the minority that do.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Share buybacks at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Halozyme Therapeutics share buybacks |url=https://companiesranked.com/en/company/halozyme-therapeutics/share-buybacks |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Halozyme Therapeutics share buybacks. CompaniesRanked. https://companiesranked.com/en/company/halozyme-therapeutics/share-buybacksBibTeX
@misc{companiesranked-en-company-halozyme-therapeutics-share-buybacks-2026,
author = {{CompaniesRanked}},
title = {{Halozyme Therapeutics share buybacks}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/halozyme-therapeutics/share-buybacks}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001159036-26-000024 · February 17, 2026
{{cite web |title=Halozyme Therapeutics share buybacks — 10-K (0001159036-26-000024) |url=https://www.sec.gov/Archives/edgar/data/1159036/000115903626000024/halo-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-17}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.